Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the […] (Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ...
Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...
U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. Elevance Health led the insurance ...
Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback